Kjellgren K I, Svensson S, Ahlner J, Säljö R
Department of Medicine and Care, Clinical Pharmacology, Faculty of Health Sciences, Linköping University, Sweden.
Int J Cardiol. 1998 Apr 1;64(2):161-9. doi: 10.1016/s0167-5273(98)00038-2.
In managing hypertension, patient participation and understanding of the nature and significance of treatment are decisive. We analysed the communication between patient and physician with respect to antihypertensive medication at a follow-up appointment, and assessed patients' knowledge of their medication. The empirical data consist of audio-recordings from 51 hypertensive patients' follow-up appointment with their physicians. Thirty-three of these patients were interviewed in depth immediately after the appointment. The study was performed in primary health care centres and at a specialist clinic for hypertension. When discussing medications, patients mainly talked about experiences of being on medication, whereas physicians generally focused on the pharmacological effect and dosage of the drug. Physicians routinely asked about compliance with drug regimen, but seldom in any depth. Little effort was invested into discussing the effect and goal of therapy. The main finding was that patients had a very fragmentary understanding of the functional nature of their antihypertensive medication. This is unsatisfactory both from the point of view of treatment efficacy and also when considering the legal requirements of involving the patient in the decision making. The follow-up appointments studied gave few possibilities for the patient to learn about their antihypertensive medication.
在管理高血压方面,患者的参与以及对治疗本质和重要性的理解起着决定性作用。我们在一次随访预约中分析了患者与医生之间关于抗高血压药物的沟通情况,并评估了患者对其所用药物的了解程度。实证数据包括51名高血压患者与医生随访预约的音频记录。其中33名患者在预约结束后立即接受了深入访谈。该研究在初级医疗保健中心和一家高血压专科诊所进行。在讨论药物时,患者主要谈论用药体验,而医生通常关注药物的药理作用和剂量。医生常规询问患者对药物治疗方案的依从性,但很少深入询问。在讨论治疗效果和目标方面投入的精力很少。主要发现是患者对其抗高血压药物的功能性质了解非常零碎。从治疗效果的角度以及考虑让患者参与决策的法律要求来看,这都是不令人满意的。所研究的随访预约几乎没有为患者提供了解其抗高血压药物的机会。